Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 1/20 | 0.38 |
| ▸ | FNTB | P49356 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.34 |
| ▸ | CA12 | O43570 | 3/20 | 0.34 |
| ▸ | CA7 | P43166 | 2/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TERT | O14746 | 1/20 | 0.33 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | RORC | P51449 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10838047 | 0.89 | KDM5A (0.39) | FNTAFNTBCA1CA12CA9 | |
| SCHEMBL10375145 | 0.84 | FNTA (0.40) | FNTAFNTBCA1CA7CA2 | |
| SCHEMBL10969272 | 0.84 | FNTA (0.40) | FNTAFNTBCA1CA7CA2 | |
| SCHEMBL2534109 | 0.84 | FNTA (0.40) | FNTAFNTBCA1CA7CA2 | |
| SCHEMBL3182370 | 0.83 | FNTA (0.47) | FNTAFNTBCA1CA7CA2 | |
| SCHEMBL28205206 | 0.83 | FNTA (0.47) | FNTAFNTBCA1CA7CA2 | |
| Trimethylammonium SCHEMBL10838652 | 0.81 | FNTA (0.43) | FNTAFNTBCA1CA7CA2 | |
| Fluoride SCHEMBL10492292 | 0.81 | FNTA (0.46) | FNTAFNTBCA1CA7CA2 | |
| SCHEMBL27257292 | 0.81 | FNTA (0.46) | FNTAFNTBCA1CA7CA2 | |
| Ammonia Solution, Strong SCHEMBL9638545 | 0.81 | FNTA (0.46) | FNTAFNTBCA1CA7CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5103046-A | PROCESS FOR THE PREPARATION OF 6-METHYL-3,4-DIHYDRO-1,2,3-OXATHIAZIN-4-ONE 2,2-DIOXIDE AND ITS NON-TOXIC SALTS, AND THE ACETOACETAMIDE-N-SULFONIC ACID (SALTS) WHICH OCCUR AS INTERMEDIATE(S) IN THIS PROCESS | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-04-07 | — | — | US | disclosed |
| US-5011982-A | Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts and the acetoacetamide-n-sulfonic acid (salts) which occur as intermediate(s) in this process | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-04-30 | — | — | US | disclosed |
| EP-0155634-B1 | PROCESS FOR THE PREPARATION OF 6-METHYL-3,4-DIHYDRO-1,2,3-OXATHIAZIN-4-ONE 2,2-DIOXIDE AND OF ITS NON-TOXIC SALTS, AS WELL AS OF ACETOACETAMIDE-N-SULFONIC ACID OCCURRING AS AN INTERMEDIARY IN THIS PROCESS, AND ITS SALTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-06-13 | — | — | EP | disclosed |
| US-4695629-A | Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-09-22 | — | — | US | disclosed |
| US-4607100-A | Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-08-19 | — | — | US | disclosed |